01—Abstract
Summary
Summary of the 10-K filed February 24, 2023. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. (ECL) reported strong top-line performance in its 2022 10-K filing, with reported sales increasing by 11% to $14.2 billiona, driven by double-digit growth across most segments.
This growth was fueled by significant pricing actions that effectively offset substantial increases in delivered product costs. While operating income remained stable, it was impacted by higher costs and strategic investments. The company's financial position remains robust, supported by an "A" range credit rating and strong cash flow generation, enabling continued investment in the business and shareholder returns through dividends and share repurchases.
Despite economic headwinds, including inflation and geopolitical instability, Ecolab maintained its commitment to sustainability and innovation, aligning its business strategy with long-term global challenges. The acquisition of Purolite in December 2021 for $3.7 billionb has been integrated and is contributing to the Life Sciences segment.
The company is also executing on various restructuring plans aimed at enhancing efficiency and streamlining operations, with significant savings anticipated in the coming years. Ecolab's focus on providing water, hygiene, and infection prevention solutions positions it well to capitalize on increasing demand for sustainability and health-focused offerings.
02—Key points
Key Highlights
- Reported sales increased 11% to $14.2 billion in 2022, driven by strong pricing and volume growth across key segments.
- Gross margin decreased slightly to 37.8% from 40.2% in the prior year, primarily due to higher delivered product costs outweighing pricing increases.
- Operating income remained stable at $1.6 billion, with adjusted operating income seeing a 1% decrease due to product cost inflation and business investments.
- Diluted EPS from continuing operations decreased 3% to $3.81, with adjusted diluted EPS down 4% to $4.49, reflecting unfavorable foreign currency translation and increased interest expense.
- Cash flow from operating activities was $1.8 billion, a decrease from $2.1 billion in 2021, impacted by increased working capital.
- The company maintained a strong balance sheet with total debt of $8.6 billion and recommitted to 'A' range credit rating metrics.
- Ecolab continued its commitment to returning capital to shareholders, increasing its quarterly dividend by 4% and marking its 31st consecutive annual dividend rate increase.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2022, Ecolab Inc. kept $0.08.
- Revenue$14.19B100.0%
- Cost of revenue−$8.83B62.2%
- Gross profit$5.36B37.8%
- Operating costs−$3.79B26.7%
- Operating income$1.56B11.0%
- Interest, other & tax−$470.8M3.3%
- Net income$1.09B7.7%
Where FY2022 revenue went
$14.19B- Cost of revenue: $8.83B, 62% of revenue
- SG&A: $3.65B, 26% of revenue
- Net income: $1.09B, 7.7% of revenue
- R&D: $190.0M, 1.3% of revenue
- Interest, other & tax: $470.8M, 3.3% of revenue
Kept 7.7% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2022filed February 24, 2023Financial Statements
FY2022 against FY2021
| Line item | FY2022FY2021 | Change |
|---|---|---|
| Revenue | $14.19B$12.73B | +11.4% |
| Cost of Revenue | $8.83B$7.62B | +16.0% |
| Gross Profit | $5.36B$5.12B | +4.7% |
| R&D Expenses | $190.00M$186.00M | +2.2% |
| SG&A Expenses | $3.65B$3.42B | +7.0% |
| Operating Income | $1.56B$1.60B | −2.3% |
| Interest Expense | $252.10M$230.60M | +9.3% |
| Net Income | $1.09B$1.14B | −4.6% |
| EPS (Basic) | $3.83$3.95 | −3.0% |
| EPS (Diluted) | $3.81$3.91 | −2.6% |
| Shares Outstanding (Basic) | 285.20M286.30M | −0.4% |
| Shares Outstanding (Diluted) | 286.60M289.10M | −0.9% |
05—Questions
Frequently Asked Questions
What was Ecolab's overall financial performance in 2022?
In 2022, Ecolab reported an 11% increase in net sales to $14.2 billion, driven by strong pricing and volume growth. However, operating income remained stable at $1.6 billion due to increased delivered product costs and strategic investments impacting margins. Diluted EPS from continuing operations decreased slightly to $3.81.
How did the acquisition of Purolite affect the company's results?
The acquisition of Purolite in December 2021 for $3.7 billion has been integrated and is reported within the Global Healthcare & Life Sciences segment. While the filing does not provide specific year-over-year performance solely for Purolite, its contribution is reflected in the segment's overall sales growth, particularly in the Life Sciences business.
What are the main challenges and risks facing Ecolab?
Ecolab faces several challenges and risks, including significant delivered product cost inflation, unfavorable foreign currency translation, and geopolitical instability (such as the conflict in Ukraine). Economic downturns in key end markets, supply chain disruptions, and cybersecurity threats are also significant risks mentioned in the filing.
What is Ecolab's approach to sustainability and its impact on the business?
Sustainability is core to Ecolab's business strategy. The company has set ambitious goals to reduce greenhouse gas emissions and water usage, both operationally and for its customers. These initiatives are seen as both a driver of business and a potential area of risk if goals are not met or stakeholder expectations are not managed.
06—Continue